Order Article Reprints

Chen J-S, Hsieh Y-C, Chou C-H, Wu Y-H, Yang M-H, Chu S-H, Chao Y-S, Chen C-N. Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice. International Journal of Molecular Sciences. 2022; 23(18):10677. https://doi.org/10.3390/ijms231810677

Chen, Jia-Shiong, Yi-Chien Hsieh, Cheng-Han Chou, Yi-Hong Wu, Mu-Hsuan Yang, Sz-Hao Chu, Ye-Su Chao, and Chia-Nan Chen. 2022. "Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice" International Journal of Molecular Sciences 23, no. 18: 10677. https://doi.org/10.3390/ijms231810677

Chen, J.-S., Hsieh, Y.-C., Chou, C.-H., Wu, Y.-H., Yang, M.-H., Chu, S.-H., Chao, Y.-S., & Chen, C.-N. (2022). Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice. International Journal of Molecular Sciences, 23(18), 10677. https://doi.org/10.3390/ijms231810677